EFFECTIVENESS AND SAFETY OF THE «DE ALEX» BIO COMPLEX AS MONOTHERAPY AND IN COMBINATION WITH TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

EFFECTIVENESS AND SAFETY OF THE «DE ALEX» BIO COMPLEX AS MONOTHERAPY AND IN COMBINATION WITH TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

Introduction. Lower urinary tract symptoms (LUTS) are a common complaint in patients with benign prostatic hyperplasia (BPH), and they significantly affect patients’ quality of life. According to the guidelines of the European Association of Urology on management of LUTS (2016), herbal drug preparat...

Full description

Bibliographic Details
Main Authors:	P. A. Scheplev, V. V. Ipatenkov, N. P. Naumov
Format:	Article
Language:	Russian
Published:	ABV-press 2017-11-01
Series:	Andrologiâ i Genitalʹnaâ Hirurgiâ
Subjects:	lower urinary tract symptoms benign prostatic hyperplasia de alex tamsulosin
Online Access:	https://agx.abvpress.ru/jour/article/view/251

Similar Items

Predictive value of the immediate effect of first dose of tamsulosin on lower urinary tract symptoms improvement in benign prostatic hyperplasia patients
by: Ayman Salah Moussa, et al.
Published: (2019-01-01)

Relation of baseline prostate volume to improvement of lower urinary tract symptoms due to tamsulosin monotherapy in benign prostatic hyperplasia: An exploratory, multicenter, prospective study
by: Mahmoud Shoukry El-Adawy, et al.
Published: (2020-01-01)

Fixed and separate combination of solifenacin and tamsulosin in urinary disorders associated with benign prostatic hyperplasia: a choice based on price and value comparison
by: A. G. Tolkushin, et al.
Published: (2019-08-01)

EFFICACY OF TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA IN TERMS OF TRIAL WITHOUT CATHETER, A RANDOMIZED CONTROL TRIAL
by: Farhan Khan, et al.
Published: (2021-08-01)

Short-term effect of tamsulosin and finasteride monotherapy and their combination on nigerian men with benign prostatic hyperplasia
by: Benjamin O Odusanya, et al.
Published: (2017-01-01)

The relation between baseline PSA and symptomatic progression in Egyptian BPH patients receiving tamsulosin monotherapy: an exploratory multicentric prospective study
by: Mahmoud S. El-Adawy, et al.
Published: (2019-12-01)

Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
by: Zhongbao Zhou, et al.
Published: (2019-03-01)

Effects of Tamsulosin Combined With Solifenacin on Lower Urinary Tract Symptoms: Evidence From a Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials
by: Yuxuan Song, et al.
Published: (2020-05-01)

Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial
by: Arcangelo Sebastianelli, et al.
Published: (2019-07-01)

The Effect of Oral Tamsulosin vs. Oral Tamsulosin and Oral Isosorbide Dinitrate in Acute Urinary Retention Patients Due to Benign Prostatic Hyperplasia: A Double-Blind Clinical Trial Study
by: Iraj Golikhatir, et al.
Published: (2020-06-01)

Comparative evaluation of naftopidil and tamsulosin in the treatment of patients with lower urinary tract symptoms with benign prostatic hyperplasia
by: Mahavir Singh Griwan, et al.
Published: (2014-01-01)

Efficacy of Tamsulosin in the Treatment of Lower Urinary Tract Symptoms (LUTS) in Women
by: Nithi Pummangura, et al.
Published: (2007-04-01)

PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
by: N. A. Avxentyev, et al.
Published: (2016-09-01)

Lower urinary tract symptoms and benign prostatic hyperplasia and their impact on quality of life
by: Antonio Carbone, et al.
Published: (2015-11-01)

Medication Adherence Pattern for Benign Prostatic Hyperplasia: A Cross-Sectional Study
by: Jyoti Tara Manandhar Shrestha, et al.
Published: (2020-10-01)

Tamsulosin plus a new complementary and alternative medicine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a retrospective comparative study
by: Ferdinando Fusco, et al.
Published: (2020-10-01)

Early versus late trail of catheter removal in patients with urinary retention secondary to benign prostatic hyperplasia under tamsulosin treatment
by: Salem Hassan Salem Mohamed, et al.
Published: (2018-01-01)

Experience with Uroflowmetry in Evaluation of Lower Urinary Tract Symptoms in Patients with Benign Prostatic Hyperplasia
by: Sanjeev Singla, et al.
Published: (2014-04-01)

Pharmacoeconomics expediency of application of the combined preparation of Vezomni in comparison with a combination of Tamsulosin and Solifenacin in the form of monopreparations
by: S. K. Zyryanov, et al.
Published: (2018-06-01)

New approaches to management of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia
by: S. I. Gamidov, et al.
Published: (2019-10-01)

Health care-seeking behavior in benign prostatic hyperplasia patients
by: Yu-Hua Fan, et al.
Published: (2017-09-01)

Prevalence of lower urinary tract symptoms in patients of benign prostatic hyperplasia attending Tertiary Care Hospital in the State of Andhra Pradesh
by: M Nagarathnam, et al.
Published: (2017-01-01)

Relationship Between Chronic Periodontitis and Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia
by: Hana Hyun, et al.
Published: (2021-03-01)

Impact of metabolic syndrome on lower urinary tract symptoms in patients with benign prostate hyperplasia
by: Dyandra Parikesit, et al.
Published: (2021-06-01)

A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement
by: Chenthil Perumal, et al.
Published: (2015-01-01)

Impact of alfuzosin on sexual function in Taiwanese men with benign prostatic hyperplasia
by: Thomas I.S. Hwang, et al.
Published: (2012-08-01)

Clinical significance of prostatic-urethral angulation on the treatment outcome of patients with symptomatic benign prostatic hyperplasia treated with tamsulosin hydrochloride
by: Hassan El-Tatawy, et al.
Published: (2015-09-01)

The Effect of Combined Therapy with Tamsulosin Hydrochloride and Meloxicam in Patients with Benign Prostatic Hyperplasia Symptoms and Impact on Nocturia and Sleep Quality
by: Sacit Nuri Gorgel, et al.
Published: (2013-09-01)

The Relationship Between Benign Prostate Hyperplasia Related Lower Urinary Tract Symptoms And Vitamin D Level in Aging Male
by: Kutluhan, Musab Ali, et al.
Published: (2020-06-01)

The Efficacy of Solifenacin Added to Α-Adrenergic Antagonists in the Treatment of Lower Urinary Tract Symptoms in Males with Benign Prostate Hyperplasia (The Iraqi Experience)
by: Nibbras I. AL-Hamdani, et al.
Published: (2015-07-01)

The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)
by: Konstantinos Stamatiou
Published: (2018-03-01)

Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia—A Spotlight in Reality
by: Yu-Chao Hsu, et al.
Published: (2016-04-01)

Association of Exercise with Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
by: Yoo-Hyun Lee, et al.
Published: (2019-02-01)

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
by: Eric H. Kim, et al.
Published: (2018-01-01)

Testosterone and benign prostatic hyperplasia
by: Thomas R Jarvis, et al.
Published: (2015-04-01)

Quick Prostate Test (QPT): Motion for a tool for the active contribution of the general pratictioner to the diagnosis and follow up of benign prostatic hyperplasia
by: Giuseppe Albino, et al.
Published: (2014-12-01)

THE EFFECTIVENESS OF TAMSULOSIN, SOLIFENACIN, AND COMBINATIONS THERAPY TAMSULOSIN ADDED SOLIFENACIN ON LOWER URINARY TRACT SYMPTOMS AFTER DOUBLE J STENT INSERTION
by: Ida Bagus Putra Pramana, et al.
Published: (2019-07-01)

A randomized comparative study of tamsulosin vs placebo in the treatment of benign prostatic hyperplasia
by: N K Mohanty, et al.
Published: (2003-01-01)

Efficacy of Tamsulosin, Oxybutynin, and their combination in the control of double-j stent-related lower urinary tract symptoms
by: Miguel Maldonado-Avila, et al.
Published: (2016-06-01)

Combination therapy in patients with benign prostatic hyperplasia
by: Bojan Tršinar
Published: (2006-11-01)